[1]
Adawiyah, R. et al. 2016. HISTONE ACETYLTRANSFERASE P300/CBP-ASSOCIATED FACTOR INHIBITION BY QUERCETIN AS ANTICANCER DRUG CANDIDATE WITH IN SILICO AND IN VITRO APPROACH. International Journal of Pharmacy and Pharmaceutical Sciences. 8, 5 (May 2016), 211–215.